Atlas Browninc Raised Its Abbvie Com (ABBV) Position; Fastenal Co (FAST) Sentiment Is 1.3

January 23, 2018 - By Dolores Ford

Fastenal Company, together with its subsidiaries, engages in the wholesale distribution of industrial and construction supplies in the United States, Canada, and internationally. The company has market cap of $15.61 billion. It offers fasteners, and other industrial and construction supplies primarily under the Fastenal name. It has a 27.06 P/E ratio. The companyÂ’s fastener products include threaded fasteners, such as bolts, nuts, screws, studs, and related washers, which are used in manufactured products and building projects, as well as in the maintenance and repair of machines and structures.

Atlas Browninc increased Abbvie Inc Com (ABBV) stake by 24.08% reported in 2017Q3 SEC filing. Atlas Browninc acquired 6,046 shares as Abbvie Inc Com (ABBV)’s stock rose 6.17%. The Atlas Browninc holds 31,155 shares with $2.77M value, up from 25,109 last quarter. Abbvie Inc Com now has $170.00B valuation. The stock increased 1.77% or $1.85 during the last trading session, reaching $106.49. About 4.54 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 23, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Ratings analysis reveals 40% of Fastenal’s analysts are positive. Out of 5 Wall Street analysts rating Fastenal, 2 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $50.0 while the high is $50.0. The stock’s average target of $50 is -7.97% below today’s ($54.33) share price. FAST was included in 5 notes of analysts from August 26, 2016. The stock has “Mkt Outperform” rating by Avondale on Thursday, January 12. As per Friday, October 14, the company rating was downgraded by Argus Research. The rating was maintained by Stifel Nicolaus on Thursday, January 19 with “Hold”. The rating was initiated by Macquarie Research on Friday, August 26 with “Neutral”. The firm has “Overweight” rating given on Thursday, January 5 by KeyBanc Capital Markets.

The stock increased 1.09% or $0.59 during the last trading session, reaching $54.33. About 3.10M shares traded or 36.46% up from the average. Fastenal Company (FAST) has declined 2.09% since January 23, 2017 and is downtrending. It has underperformed by 18.79% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 3 selling transactions for $956,223 activity.

Mcdonald Capital Investors Inc Ca holds 8.89% of its portfolio in Fastenal Company for 2.29 million shares. Bares Capital Management Inc. owns 3.66 million shares or 7.53% of their US portfolio. Moreover, Wedgewood Partners Inc has 5.76% invested in the company for 3.70 million shares. The California-based Route One Investment Company L.P. has invested 5.46% in the stock. Marshfield Associates, a -based fund reported 1.57 million shares.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It dropped, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Mackenzie Fincl Corp reported 357,204 shares. Barton Inv has 8,994 shares for 0.19% of their portfolio. Asset Advsrs Corp has 1.7% invested in AbbVie Inc. (NYSE:ABBV) for 107,315 shares. Advisor Prtnrs reported 34,878 shares. Cetera Ltd accumulated 47,796 shares. Janney Montgomery Scott Ltd Liability reported 0.56% of its portfolio in AbbVie Inc. (NYSE:ABBV). Panagora Asset holds 0.26% in AbbVie Inc. (NYSE:ABBV) or 750,523 shares. Moreover, Campbell And Com Inv Adviser Limited Liability Corp has 0.16% invested in AbbVie Inc. (NYSE:ABBV) for 2,293 shares. Jones Fincl Lllp holds 0.01% or 33,126 shares in its portfolio. Marble Harbor Investment Counsel Ltd Liability Corporation stated it has 3.63% of its portfolio in AbbVie Inc. (NYSE:ABBV). Legacy Prtnrs reported 2.76% stake. Mirador Cap Partners Limited Partnership invested in 19,297 shares or 1.02% of the stock. Atlas Browninc invested in 31,155 shares or 0.59% of the stock. Retail Bank Of America De owns 19.74 million shares or 0.28% of their US portfolio. 3,820 are held by Sonata Cap Inc.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc has $130.0 highest and $6 lowest target. $83.78’s average target is -21.33% below currents $106.49 stock price. Abbvie Inc had 71 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, June 26 by Jefferies. As per Monday, October 31, the company rating was downgraded by Credit Suisse. TheStreet upgraded the stock to “Buy” rating in Tuesday, August 11 report. The stock has “Outperform” rating by Leerink Swann on Monday, October 2. The stock has “Hold” rating by Cowen & Co on Friday, July 28. The firm earned “Buy” rating on Monday, July 17 by Jefferies. The firm has “Buy” rating given on Monday, October 16 by SunTrust. As per Thursday, January 4, the company rating was maintained by Jefferies. SunTrust maintained the stock with “Buy” rating in Sunday, October 29 report. Deutsche Bank upgraded the stock to “Hold” rating in Thursday, September 28 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts